Clinical Trial

Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France

Study acronym: PrimoAVIH
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Migrants living with HIV - whether the infection was diagnosed in their country of origin or in France- frequently experience vulnerabilities related to their migration trajectories and often face socioeconomic and administrative instability upon arrival . The primary outcome of this study is to compare the immunovirological efficacy of antiretroviral therapy among migrants living with HIV patients according to their social and administrative status.
Trial Details
NCT Number NCT07691424
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions HIV - Human Immunodeficiency Virus, Socio-economic Status, Migrants
Enrollment 150 participants
Start Date 2026-07-15
Primary Completion 2029-02-15 (estimated)
Study Completion 2030-02-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-08